Results 31 to 40 of about 387,869 (336)

The role of provider characteristics on the hepatitis A and B vaccination status of adults in the United States during 2007–2015

Preventive Medicine Reports, 2019
Hepatitis A and B vaccine coverage is suboptimal in US adults, even among those at increased risk for infection, morbidity, or mortality. To understand where medical education and resources might enhance vaccine coverage, it is important to first ...
P.K. Ghaswalla, B.J. Patterson, W.Y. Cheng, E. Duchesneau, M. Macheca, M.S. Duh, A.F. Trofa   +6 more
doaj   +1 more source

Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant

MMWR. Morbidity and mortality weekly report, 2018
Hepatitis B (HepB) vaccination is the primary means of preventing infections and complications caused by hepatitis B virus (HBV). On February 21, 2018, the Advisory Committee on Immunization Practices (ACIP) recommended Heplisav-B (HepB-CpG), a yeast ...
S. Schillie, A. Harris, R. Link-Gelles, J. Romero, J. Ward, Noele P. Nelson   +5 more
semanticscholar   +1 more source

Research progress of hepatitis B virus and its vaccine [PDF]

BIO Web of Conferences
Hepatitis B is a serious worldwide public health problem with a very high incidence. It is caused by the hepatitis B virus (HBV), and vaccination is the primary preventive measure. However, vaccine non-response or weak immune responses remain a challenge.
Huang Zhenghuai
doaj   +1 more source

Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study

Vaccines, 2023
To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population.
Putri Bungsu Machmud, Amand Führer, Cornelia Gottschick, Rafael Mikolajczyk   +3 more
doaj   +1 more source

Hepatitis B Vaccine

Reactions weekly
Hodgens A, Marathi R.
europepmc   +2 more sources

Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial

Althea Medical Journal, 2023
Background: In order to fulfil the requirements of the national immunization program and sustain the production capacity of the monovalent Hepatitis B vaccine, this study aimed to assess the safety and immunogenicity of the recombinant Hepatitis B ...
Eddy Fadlyana, Rodman Tarigan, Kusnandi Rusmil, Rini Mulia Sari, Cissy B Kartasmita, Behesti Zahra Mardiah, Muhammad Gilang Dwi Putra   +6 more
doaj   +1 more source

Timing of Hepatitis B Vaccine Birth Dose in Exposed Newborns, Southwest Ethiopia: A Cross-Sectional Study

SAGE Open Nursing, 2023
Introduction Hepatitis B virus disease is a global acute and chronic communicable disease. Mother-to-child transmission is the reason for high carrier rates.
Mebratu Demissie MSc, Haregwa Asnake Weldekidan MSc, Yirgalem Yosef MSc, Seboka Abebe Sori MSc, Daniel Tsega MSc, Hirut Dinku Jiru MSc, Aberash Beyene Derribow MSc, Mesfin Difer Tetema MSc, Gudeta Beriso Jima MSc, Fentahun Temene Zeleke MSc, Fikremariam Endeshew MSc, Seblework Abeje MSc   +11 more
doaj   +1 more source

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants

Vaccines, 2022
Introduction: The World Health Organization (WHO) recommends all newborn infants receive the first dose of the hepatitis B vaccine within 24 h of birth irrespective of maternal hepatitis B carrier status.
Donna Lei, Taryn Miller, Jeremy Carr, Jim Buttery, Claudia A. Nold-Petry, Marcel F. Nold, Atul Malhotra   +6 more
doaj   +1 more source

Hepatitis B Vaccine and Immunoglobulin: Key Concepts

Journal of Clinical and Translational Hepatology, 2019
Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine practice. The target of such vaccination is to induce the immune response in the host, resulting in the prevention of replication of HBV.
S. Das, K. Ramakrishnan, S. Behera, Mahalakshmi Ganesapandian, A. S. Xavier, S. Selvarajan   +5 more
semanticscholar   +1 more source

Hepatitis B vaccine

Journal of Pediatric Health Care, 1999
Hepatitis B virus (HBV) infection is a health problem that affects numerous infants and children in the United States. Approximately 4000 to 6000 new infections occur each year in children and adolescents; most often they become infected without obvious clinical manifestations. Some persons become chronically infected, and this asymptomatic chronically
Mary Jane Ott, Mary Aruda
openaire   +6 more sources